close
Jump to content

Veeva Systems

From Wikipedia, the free encyclopedia
Veeva Systems Inc.
TypePublic benefit corporation
IndustrySoftware for life sciences
Founded2007; 19 years ago (2007)
Founders
Headquarters,
U.S.
Key people
ProductsSoftware
ServicesBusiness consulting
RevenueIncrease US$3.195 billion (FY 2026)
Increase US$916 million (FY 2026)
Increase US$908 million (FY 2026)
Total assetsIncrease US$8.979 billion (FY 2026)
Total equityIncrease US$7.214 billion (FY 2026)
Number of employees
7,928 (2026)
Websiteveeva.com
Footnotes
[1][2]

Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud computing software, data, and consulting services for the life sciences industry.[1] Its products are used to track all aspects of drug development and pharmaceutical manufacturing.[1]

The company has 1,552 customers including Bayer, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Merck & Co., Novartis, Alkermes plc, Alnylam Pharmaceuticals, bluebird bio, and Idorsia.[1] Its primary competitor for its customer relationship management software is Salesforce, which is partnered with IQVIA.[1]

History

[edit]

Veeva was founded in 2007 by Peter Gassner and Matt Wallach.[2]

In 2011, the company introduced Veeva Vault, a content management system for the life sciences industry.[3]

In October 2013, Veeva became a public company via an initial public offering on the New York Stock Exchange.[4][5]

In February 2021, Veeva became the first publicly traded company to convert to a public benefit corporation.[6]

In 2025, Veeva ended its partnership with Salesforce, a competitor.[7]

Acquisitions

[edit]
# Date Company Notes Ref.
1 October 2015 Zinc Ahead Content management software company [8]
2 October 2019 Crossix Medical privacy-safe patient data and analytics company [9]
3 November 2019 Physicians World Provider of business process outsourcing services [10]
4 August 2021 Learnaboutgmp Compliance training services for life sciences organizations [11]
5 December 2021 Veracity Logic Provider of cloud software for randomization and trial supply management [12]
6 March 2026 Ostro Patient and HCP engagement with AI agents for life sciences; price was $100 milllion [13]

References

[edit]
  1. 1 2 3 4 5 "Veeva Systems, Inc. Annual Report fiscal year ending January 31, 2026 (Form 10-K)". U.S. Securities and Exchange Commission. March 20, 2026.
  2. 1 2 "Peter Gassner Profile". Forbes.
  3. "Veeva Systems Introduces New Regulated Content Management Solution for Life Sciences" (Press release). February 15, 2011 via Biospace.
  4. Gage, Deborah (October 16, 2013). "Veeva Systems Soars in IPO In Win For Biotech Cloud Software". The Wall Street Journal.
  5. Aggarwal, Varun; Das, Avik (October 16, 2013). "Cloud company Veeva's shares nearly double in debut". Reuters.
  6. Rinker, Brian (January 27, 2021). "Veeva Systems is now a public benefit corporation. But what does that mean?". American City Business Journals.
  7. Ford, Brody (December 24, 2024). "Salesforce Stokes Veeva Fight by Snagging Drug Customers". Bloomberg Law.
  8. "Veeva scoops up rival Zinc Ahead to create mega-content management platform". Fierce Pharma (Press release). Questex. October 5, 2015.
  9. Bulik, Beth Snyder (October 2, 2019). "Veeva acquires Crossix, pairing doctor, patient data and marketing services". Fierce Pharma. Questex.
  10. "Veeva Acquires Physicians World" (Press release). Business Wire. November 7, 2019.
  11. "Veeva Systems Inc. acquired Learnaboutgmp LLC". S&P Global. August 2, 2021.
  12. "Veeva Systems Inc. acquired Veracity Logic, LLC". S&P Global. December 12, 2021.
  13. Park, Andrea (March 11, 2026). "Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement". Fierce Pharma. Questex.
[edit]
  • Official website
  • Business data for Veeva Systems Inc.: